Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer.

BACKGROUND & AIMS The DNA/RNA editing enzyme activation-induced cytidine deaminase (AID) is mutagenic and has been implicated in human tumorigenesis. Helicobacter pylori infection of gastric epithelial cells leads to aberrant expression of AID and somatic gene mutations. We investigated whether AID induces genetic aberrations at specific chromosomal loci that encode tumor-related proteins in gastric epithelial cells. METHODS Human gastric epithelial cell lines that express activated AID and gastric cells from AID transgenic mice were examined for DNA copy number changes and nucleotide alterations. Copy number aberrations in stomach cells of H pylori-infected mice and gastric tissues (normal and tumor) from H pylori-positive patients were also analyzed. RESULTS In human gastric cells, aberrant AID activity induced copy number changes at various chromosomal loci. In AID-expressing cells and gastric mucosa of AID transgenic mice, point mutations and reductions in copy number were observed frequently in the tumor suppressor genes CDKN2A and CDKN2B. Oral infection of wild-type mice with H pylori reduced the copy number of the Cdkn2b-Cdkn2a locus, whereas no such changes were observed in the gastric mucosa of H pylori-infected AID-deficient mice. In human samples, the relative copy numbers of CDKN2A and CDKN2B were reduced in a subset of gastric cancer tissues compared with the surrounding noncancerous region. CONCLUSIONS H pylori infection leads to aberrant expression of AID and might be a mechanism of the accumulation of submicroscopic deletions and somatic mutations in gastric epithelial cells. AID-mediated genotoxic effects appear to occur frequently at the CDKN2b-CDKN2a locus and contribute to malignant transformation of the gastric mucosa.

[1]  H. Marusawa,et al.  A novel mechanism for inflammation-associated carcinogenesis; an important role of activation-induced cytidine deaminase (AID) in mutation induction , 2009, Journal of Molecular Medicine.

[2]  M. Lieber,et al.  The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.

[3]  G. Bornkamm,et al.  Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers , 2009, International journal of cancer.

[4]  M. Potter,et al.  Restricting activation‐induced cytidine deaminase tumorigenic activity in B lymphocytes , 2009, Immunology.

[5]  T. Honjo,et al.  A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations , 2009, Oncogene.

[6]  T. Honjo,et al.  Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression , 2008, International journal of cancer.

[7]  M. Nussenzweig,et al.  AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations , 2008, Cell.

[8]  R. Siebert,et al.  Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.

[9]  T. Honjo,et al.  Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. , 2008, Gastroenterology.

[10]  F. Alt,et al.  AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development , 2008, The Journal of experimental medicine.

[11]  K. Kinoshita,et al.  Activation‐induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma , 2008, Hepatology.

[12]  T. Ried,et al.  AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements , 2007, The Journal of experimental medicine.

[13]  M. Nussenzweig,et al.  A role for AID in chromosome translocations between c-myc and the IgH variable region , 2007, The Journal of experimental medicine.

[14]  T. Honjo,et al.  Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling , 2007, Oncogene.

[15]  T. Honjo,et al.  Detection of activation-induced cytidine deaminase in gastric epithelial cells infected with cag pathogenicity island-positive Helicobacter pylori , 2007 .

[16]  Takeshi Azuma,et al.  Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium , 2007, Nature Medicine.

[17]  T. Ushijima Epigenetic field for cancerization. , 2007, Journal of biochemistry and molecular biology.

[18]  K. Kinoshita,et al.  Expression of activation‐induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis , 2007, International journal of cancer.

[19]  W. Hofmann,et al.  Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells , 2007, The Journal of experimental medicine.

[20]  N. Sharpless,et al.  The Regulation of INK4/ARF in Cancer and Aging , 2006, Cell.

[21]  J. Yokota,et al.  Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer: deduction from structural analysis of breakpoints for deletions. , 2006, DNA repair.

[22]  G. Peters,et al.  Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.

[23]  T. Ushijima,et al.  DNA methylation as a marker for the past and future , 2006, Journal of Gastroenterology.

[24]  K. Kinoshita,et al.  The Dark Side of Activation-Induced Cytidine Deaminase: Relationship with Leukemia and Beyond , 2006, International journal of hematology.

[25]  Michel C. Nussenzweig,et al.  Role of genomic instability and p53 in AID-induced c-myc–Igh translocations , 2006, Nature.

[26]  G. Tamura Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. , 2006, World journal of gastroenterology.

[27]  A. Levine,et al.  Eradication of Helicobacter pylori and Resolution of Gastritis in the Gastric Mucosa of IL‐10‐Deficient Mice , 2005, Helicobacter.

[28]  M. Nussenzweig,et al.  AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.

[29]  U. Storb,et al.  The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. , 2003, Immunity.

[30]  Hui Zhang,et al.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA , 2003, Nature.

[31]  N. Kakazu,et al.  Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.

[32]  J. Wedekind,et al.  Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. , 2003, Trends in genetics : TIG.

[33]  T. Honjo,et al.  De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Lowe,et al.  Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.

[35]  Jun Yu,et al.  Promoter hypermethylation of tumor‐related genes in gastric intestinal metaplasia of patients with and without gastric cancer , 2002, International journal of cancer.

[36]  William C Hahn,et al.  Rules for making human tumor cells. , 2002, The New England journal of medicine.

[37]  K. Okazaki,et al.  Analysis of Cytokines in the Early Development of Gastric Secondary Lymphoid Follicles in Helicobacter pylori-Infected BALB/c Mice with Neonatal Thymectomy , 2001, Infection and Immunity.

[38]  Jun Yu,et al.  Concurrent hypermethylation of multiple tumor‐related genes in gastric carcinoma and adjacent normal tissues , 2001, Cancer.

[39]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[40]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[41]  T. Dryja,et al.  Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Marusawa Aberrant AID expression and human cancer development. , 2008, The international journal of biochemistry & cell biology.

[43]  R. Kefford,et al.  The ARF tumour suppressor. , 2006, The international journal of biochemistry & cell biology.

[44]  T. Honjo,et al.  Molecular mechanism of class switch recombination: linkage with somatic hypermutation. , 2002, Annual review of immunology.

[45]  S. Korsmeyer,et al.  Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. , 1992, Annual review of immunology.